These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

438 related articles for article (PubMed ID: 19037805)

  • 1. Preclinical safety and pharmacology of an anti-human interleukin-13 monoclonal antibody in normal macaques and in macaques with allergic asthma.
    Martin PL; Fisher D; Glass W; O'Neil K; Das A; Martin EC; Li L
    Int J Toxicol; 2008; 27(5):351-8. PubMed ID: 19037805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preclinical efficacy and safety of mepolizumab (SB-240563), a humanized monoclonal antibody to IL-5, in cynomolgus monkeys.
    Hart TK; Cook RM; Zia-Amirhosseini P; Minthorn E; Sellers TS; Maleeff BE; Eustis S; Schwartz LW; Tsui P; Appelbaum ER; Martin EC; Bugelski PJ; Herzyk DJ
    J Allergy Clin Immunol; 2001 Aug; 108(2):250-7. PubMed ID: 11496242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro and in vivo characterisation of anti-murine IL-13 antibodies recognising distinct functional epitopes.
    Berry LM; Adams R; Airey M; Bracher MG; Bourne T; Carrington B; Cross AS; Davies GC; Finney HM; Foulkes R; Gozzard N; Griffin RA; Hailu H; Lamour SD; Lawson AD; Lightwood DJ; McKnight AJ; O'Dowd VL; Oxbrow AK; Popplewell AG; Shaw S; Stephens PE; Sweeney B; Tomlinson KL; Uhe C; Palframan RT
    Int Immunopharmacol; 2009 Feb; 9(2):201-6. PubMed ID: 19041426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-13 blockade reduces lung inflammation after Ascaris suum challenge in cynomolgus monkeys.
    Bree A; Schlerman FJ; Wadanoli M; Tchistiakova L; Marquette K; Tan XY; Jacobson BA; Widom A; Cook TA; Wood N; Vunnum S; Krykbaev R; Xu X; Donaldson DD; Goldman SJ; Sypek J; Kasaian MT
    J Allergy Clin Immunol; 2007 May; 119(5):1251-7. PubMed ID: 17379289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-13 neutralization by two distinct receptor blocking mechanisms reduces immunoglobulin E responses and lung inflammation in cynomolgus monkeys.
    Kasaian MT; Tan XY; Jin M; Fitz L; Marquette K; Wood N; Cook TA; Lee J; Widom A; Agostinelli R; Bree A; Schlerman FJ; Olland S; Wadanoli M; Sypek J; Gill D; Goldman SJ; Tchistiakova L
    J Pharmacol Exp Ther; 2008 Jun; 325(3):882-92. PubMed ID: 18337474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel recombinant interleukin-13 peptide-based vaccine reduces airway allergic inflammatory responses in mice.
    Ma Y; HayGlass KT; Becker AB; Fan Y; Yang X; Basu S; Srinivasan G; Simons FE; Halayko AJ; Peng Z
    Am J Respir Crit Care Med; 2007 Sep; 176(5):439-45. PubMed ID: 17556715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of lactose-beta-sitosterol and beta-sitosterol on ovalbumin-induced lung inflammation in actively sensitized mice.
    Yuk JE; Woo JS; Yun CY; Lee JS; Kim JH; Song GY; Yang EJ; Hur IK; Kim IS
    Int Immunopharmacol; 2007 Dec; 7(12):1517-27. PubMed ID: 17920528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A role for CD44 in an antigen-induced murine model of pulmonary eosinophilia.
    Katoh S; Matsumoto N; Kawakita K; Tominaga A; Kincade PW; Matsukura S
    J Clin Invest; 2003 May; 111(10):1563-70. PubMed ID: 12750406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eotaxin-2 and IL-5 cooperate in the lung to regulate IL-13 production and airway eosinophilia and hyperreactivity.
    Yang M; Hogan SP; Mahalingam S; Pope SM; Zimmermann N; Fulkerson P; Dent LA; Young IG; Matthaei KI; Rothenberg ME; Foster PS
    J Allergy Clin Immunol; 2003 Nov; 112(5):935-43. PubMed ID: 14610483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of human interleukin-13-induced respiratory and oesophageal inflammation by anti-human-interleukin-13 antibody (CAT-354).
    Blanchard C; Mishra A; Saito-Akei H; Monk P; Anderson I; Rothenberg ME
    Clin Exp Allergy; 2005 Aug; 35(8):1096-103. PubMed ID: 16120093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of STAT6 and SMAD2 in a model of chronic allergen exposure: a mouse strain comparison study.
    Hirota JA; Ask K; Fritz D; Ellis R; Wattie J; Richards CD; Labiris R; Kolb M; Inman MD
    Clin Exp Allergy; 2009 Jan; 39(1):147-58. PubMed ID: 19032363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-IL-33 antibody treatment inhibits airway inflammation in a murine model of allergic asthma.
    Liu X; Li M; Wu Y; Zhou Y; Zeng L; Huang T
    Biochem Biophys Res Commun; 2009 Aug; 386(1):181-5. PubMed ID: 19508862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Anti-inflammatory and anti-allergic effects of acidic fraction of Pheratima extract in asthma mice induced by ovalbumin].
    Zhou MM; Chu XP; Yang HZ; Kou F; Zhao AH; Jia W
    Zhongguo Zhong Yao Za Zhi; 2008 Oct; 33(19):2249-52. PubMed ID: 19166019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-13 and the IL-13 receptor as therapeutic targets for asthma and allergic disease.
    Mitchell J; Dimov V; Townley RG
    Curr Opin Investig Drugs; 2010 May; 11(5):527-34. PubMed ID: 20419598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A study to evaluate safety and efficacy of mepolizumab in patients with moderate persistent asthma.
    Flood-Page P; Swenson C; Faiferman I; Matthews J; Williams M; Brannick L; Robinson D; Wenzel S; Busse W; Hansel TT; Barnes NC;
    Am J Respir Crit Care Med; 2007 Dec; 176(11):1062-71. PubMed ID: 17872493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhaled vs subcutaneous effects of a dual IL-4/IL-13 antagonist in a monkey model of asthma.
    Tomkinson A; Tepper J; Morton M; Bowden A; Stevens L; Harris P; Lindell D; Fitch N; Gundel R; Getz EB
    Allergy; 2010 Jan; 65(1):69-77. PubMed ID: 19796211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blockade of interleukin-13-mediated cell activation by a novel inhibitory antibody to human IL-13 receptor alpha1.
    Krause S; Behrends J; Borowski A; Lohrmann J; Lang S; Myrtek D; Lorenzen T; Virchow JC; Luttmann W; Friedrich K
    Mol Immunol; 2006 Apr; 43(11):1799-807. PubMed ID: 16364441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinetics of IL-10 production after segmental antigen challenge of atopic asthmatic subjects.
    Colavita AM; Hastie AT; Musani AI; Pascual RM; Reinach AJ; Lustine HT; Galati SA; Zangrilli JG; Fish JE; Peters SP
    J Allergy Clin Immunol; 2000 Nov; 106(5):880-6. PubMed ID: 11080710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunoglobulin E: role in asthma and allergic disease: lessons from the clinic.
    Owen CE
    Pharmacol Ther; 2007 Jan; 113(1):121-33. PubMed ID: 17000005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Polynuclear basophils, the key to allergic reactions. Modulations by chemokines].
    Devouassoux G
    Rev Mal Respir; 2000 Jun; 17(3):629-40. PubMed ID: 10951958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.